Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Hackensack Meridian Health
University Hospital, Lille
Hackensack Meridian Health
National Cancer Institute (NCI)
University of Arkansas
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
University of Alabama at Birmingham
Stichting Hemato-Oncologie voor Volwassenen Nederland
City of Hope Medical Center
University of Turin, Italy
National Cancer Institute (NCI)
Thomas Jefferson University
University of Iowa
University of Rochester
University of Arkansas
Washington University School of Medicine
Janssen Research & Development, LLC
University of Arkansas
University of Arkansas
City of Hope Medical Center
City of Hope Medical Center
Emory University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
Janssen Research & Development, LLC